Molecular evidence of osteoblast dysfunction in elderly men with osteoporotic hip fractures

Experimental Gerontology

Volumn 57, Issue , 2014, Pages 114-121

  Föger Samwald, Ursula ^a   Patsch, Janina M ^a,b   Schamall, Doris ^a   Alaghebandan, Afarin ^a   Deutschmann, Julia ^a   Salem, Sylvia ^c   Mousavi, Mehdi ^d   Pietschmann, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c St Vincent Hospital Vienna   (Austria)

^d DANUBE HOSPITAL   (Austria)

Author keywords

Bone formation; Gene expression; Hip fracture; Osteoporosis

Indexed keywords

MESSENGER RNA; SCLEROSTIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

AGED; ARTICLE; BONE DISEASE; BONE MASS; BONE STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMUR HEAD; FEMUR NECK; FRAGILITY FRACTURE; GENE EXPRESSION; GENETIC ASSOCIATION; HIP ARTHROPLASTY; HIP FRACTURE; HIP OSTEOARTHRITIS; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; OSTEOBLAST DYSFUNCTION; OSTERIX GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RUNX2 GENE; SOST GENE; VERY ELDERLY; COMPARATIVE STUDY; FEMUR; GENE EXPRESSION PROFILING; HIP FRACTURES; METABOLISM; OSTEOBLAST; OSTEOPOROTIC FRACTURES; PATHOLOGY;

AGED; AGED, 80 AND OVER; FEMUR; GENE EXPRESSION PROFILING; HIP FRACTURES; HUMANS; MALE; OSTEOARTHRITIS, HIP; OSTEOBLASTS; OSTEOPOROTIC FRACTURES;

EID: 84901982956     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.05.014     Document Type: Article

References (49)

1. Abdallah B.M., Stilgren L.S., Nissen N., Kassem M., Jorgensen H.R., Abrahamsen B. Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcif. Tissue Int. 2005, 76:90-97.
2. Ardawi M.S., Rouzi A.A., Al-Sibiani S.A., Al-Senani N.S., Qari M.H., Mousa S.A. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study. J. Bone Miner. Res. 2012, 27:2592-2602.
3. Benisch P., Schilling T., Klein-Hitpass L., Frey S.P., Seefried L., Raaijmakers N., Krug M., Regensburger M., Zeck S., Schinke T., Amling M., Ebert R., Jakob F. The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS One 2012, 7:e45142.
4. Boutroy S., Vilayphiou N., Roux J.P., Delmas P.D., Blain H., Chapurlat R.D., Chavassieux P. Comparison of 2D and 3D bone microarchitecture evaluation at the femoral neck, among postmenopausal women with hip fracture or hip osteoarthritis. Bone 2011, 49:1055-1061.
5. Ciria-Recasens M., Perez-Edo L., Blanch-Rubio J., Marinoso M.L., Benito-Ruiz P., Serrano S., Carbonell-Abello J. Bone histomorphometry in 22 male patients with normocalciuric idiopathic osteoporosis. Bone 2005, 36:926-930.
6. Clarke B.L., Khosla S. Physiology of bone loss. Radiol. Clin. North Am. 2010, 48:483-495.
7. Cui W.Q., Won Y.Y., Baek M.H., Lee D.H., Chung Y.S., Hur J.H., Ma Y.Z. Age-and region-dependent changes in three-dimensional microstructural properties of proximal femoral trabeculae. Osteoporos. Int. 2008, 19:1579-1587.
8. de Vernejoul M.C., Kornak U. Heritable sclerosing bone disorders: presentation and new molecular mechanisms. Ann. N. Y. Acad. Sci. 2010, 1192:269-277.
9. Delgado-Calle J., Arozamena J., Garcia-Renedo R., Garcia-Ibarbia C., Pascual-Carra M.A., Gonzalez-Macias J., Riancho J.A. Osteocyte deficiency in hip fractures. Calcif. Tissue Int. 2011, 89:327-334.
10. Dempster D.W., Compston J.E., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R., Parfitt A.M. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2013, 28:2-17.
11. Dequeker J., Aerssens J., Luyten F.P. Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin. Exp. Res. 2003, 15:426-439.
12. Djuric M., Djonic D., Milovanovic P., Nikolic S., Marshall R., Marinkovic J., Hahn M. Region-specific sex-dependent pattern of age-related changes of proximal femoral cancellous bone and its implications on differential bone fragility. Calcif. Tissue Int. 2010, 86:192-201.
13. Dovjak P., Dorfer S., Föger-Samwald U., Kudlacek S., Marculescu R., Pietschmann P. Serum levels of sclerostin and dickkopf-1: effects of age, gender, and fracture status. Gerontology 2014, (in press).
14. Dragojevic J., Logar D.B., Komadina R., Marc J. Osteoblastogenesis and adipogenesis are higher in osteoarthritic than in osteoporotic bone tissue. Arch. Med. Res. 2011, 42:392-397.
15. Dragojevic J., Zupan J., Haring G., Herman S., Komadina R., Marc J. Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: a gene expression study. J. Bone Miner. Metab. 2013, 31:512-519.
16. Fratzl-Zelman N., Roschger P., Misof B.M., Nawrot-Wawrzyniak K., Potter-Lang S., Muschitz C., Resch H., Klaushofer K., Zwettler E. Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover. Calcif. Tissue Int. 2011, 88:378-387.
17. Gielen E., Vanderschueren D., Callewaert F., Boonen S. Osteoporosis in men. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25:321-335.
18. Giner M., Montoya M.J., Vazquez M.A., Miranda C., Perez-Cano R. Differences in osteogenic and apoptotic genes between osteoporotic and osteoarthritic patients. BMC Musculoskelet. Disord. 2013, 14:41.
19. Henrotin Y., Pesesse L., Sanchez C. Subchondral bone and osteoarthritis: biological and cellular aspects. Osteoporos. Int. 2012, 23(Suppl. 8):S847-S851.
20. Hordon L.D., Peacock M. The architecture of cancellous and cortical bone in femoral neck fracture. Bone Miner. 1990, 11:335-345.
21. Hu H.M., Yang L., Wang Z., Liu Y.W., Fan J.Z., Fan J., Liu J., Luo Z.J. Overexpression of integrin a2 promotes osteogenic differentiation of hBMSCs from senile osteoporosis through the ERK pathway. Int. J. Clin. Exp. Pathol. 2013, 6:841-852.
22. Im G.I., Kim M.K. The relationship between osteoarthritis and osteoporosis. J. Bone Miner. Metab. 2014, 32:101-109.
23. Johansson A.G., Eriksen E.F., Lindh E., Langdahl B., Blum W.F., Lindahl A., Ljunggren O., Ljunghall S. Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J. Clin. Endocrinol. Metab. 1997, 82:2795-2798.
24. Johnell O., Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 2006, 17:1726-1733.
25. Kang S., Bennett C.N., Gerin I., Rapp L.A., Hankenson K.D., Macdougald O.A. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2007, 282:14515-14524.
26. Katagiri T., Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis. 2002, 8:147-159.
27. Khosla S. Update in male osteoporosis. J. Clin. Endocrinol. Metab. 2010, 95:3-10.
28. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
29. Kurland E.S., Rosen C.J., Cosman F., McMahon D., Chan F., Shane E., Lindsay R., Dempster D., Bilezikian J.P. Insulin-like growth factor-I in men with idiopathic osteoporosis. J. Clin. Endocrinol. Metab. 1997, 82:2799-2805.
30. Li Z.C., Dai L.Y., Jiang L.S., Qiu S. Difference in subchondral cancellous bone between postmenopausal women with hip osteoarthritis and osteoporotic fracture: implication for fatigue microdamage, bone microarchitecture, and biomechanical properties. Arthritis Rheum. 2012, 64:3955-3962.
31. Logar D.B., Komadina R., Prezelj J., Ostanek B., Trost Z., Marc J. Expression of bone resorption genes in osteoarthritis and in osteoporosis. J. Bone Miner. Metab. 2007, 25:219-225.
32. Marie P.J., de Vernejoul M.C., Connes D., Hott M. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J. Clin. Invest. 1991, 88:1167-1172.
33. Melton L.J., Chrischilles E.A., Cooper C., Lane A.W., Riggs B.L. Perspective. How many women have osteoporosis?. J. Bone Miner. Res. 1992, 7:1005-1010.
34. Milovanovic P., Djonic D., Marshall R.P., Hahn M., Nikolic S., Zivkovic V., Amling M., Djuric M. Micro-structural basis for particular vulnerability of the superolateral neck trabecular bone in the postmenopausal women with hip fractures. Bone 2012, 50:63-68.
35. Mirza F.S., Padhi I.D., Raisz L.G., Lorenzo J.A. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J. Clin. Endocrinol. Metab. 2010, 95:1991-1997.
36. Monroe D.G., McGee-Lawrence M.E., Oursler M.J., Westendorf J.J. Update on Wnt signaling in bone cell biology and bone disease. Gene 2012, 492:1-18.
37. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
38. Patsch J.M., Kohler T., Berzlanovich A., Muschitz C., Bieglmayr C., Roschger P., Resch H., Pietschmann P. Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis. J. Bone Miner. Res. 2011, 26:1584-1592.
39. Pernow Y., Granberg B., Saaf M., Weidenhielm L. Osteoblast dysfunction in male idiopathic osteoporosis. Calcif. Tissue Int. 2006, 78:90-97.
40. Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: now and the future. Lancet 2011, 377:1276-1287.
41. Rossini M., Gatti D., Adami S. Involvement of WNT/beta-catenin signaling in the treatment of osteoporosis. Calcif. Tissue Int. 2013, 93:121-132.
42. Ruiz-Gaspa S., Blanch-Rubio J., Ciria-Recasens M., Monfort J., Tio L., Garcia-Giralt N., Nogues X., Monllau J.C., Carbonell-Abello J., Perez-Edo L. Reduced proliferation and osteocalcin expression in osteoblasts of male idiopathic osteoporosis. Calcif. Tissue Int. 2010, 86:220-226.
43. Tsangari H., Findlay D.M., Kuliwaba J.S., Atkins G.J., Fazzalari N.L. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone 2004, 35:334-342.
44. Uitewaal P.J., Lips P., Netelenbos J.C. An analysis of bone structure in patients with hip fracture. Bone Miner. 1987, 3:63-73.
45. van Bezooijen R.L., Roelen B.A., Visser A., van der Wee-Pals L., de Wilt E., Karperien M., Hamersma H., Papapoulos S.E., ten Dijke P., Lowik C.W. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 2004, 199:805-814.
46. Winkler D.G., Sutherland M.K., Geoghegan J.C., Yu C., Hayes T., Skonier J.E., Shpektor D., Jonas M., Kovacevich B.R., Staehling-Hampton K., Appleby M., Brunkow M.E., Latham J.A. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003, 22:6267-6276.
47. Zerwekh J.E., Sakhaee K., Breslau N.A., Gottschalk F., Pak C.Y. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos. Int. 1992, 2:128-134.
48. Zupan J., Komadina R., Marc J. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. J. Biomed. Sci. 2012, 19:28.
49. Zupan J., van't Hof R.J., Vindisar F., Haring G., Trebse R., Komadina R., Marc J. Osteoarthritic versus osteoporotic bone and intra-skeletal variations in normal bone: evaluation with microCT and bone histomorphometry. J. Orthop. Res. 2013, 31:1059-1066.